Concepedia

Ahmed Awad

AA

Statistics

Publications

4

Citations

357

H-Index

4

Active since

2020

Affiliations

Cara Therapeutics (United States)(Current)

Ahmed Awad is an author at Cara Therapeutics (United States) specializing in medicine, hemodialysis, and pharmacotherapy.

ORCID

Publications per year

2020–2023

4

Publications

4

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 227 citations · Full text

, , +14

Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients

Steven Fishbane, Vandana Mathur, Michael J. Germain et al. · Kidney International Reports · 2020 · 88 citations · Full text

, , +17

A phase 2 study of oral difelikefalin in subjects with chronic kidney disease and moderate-to-severe pruritus

Gil Yosipovitch, Ahmed Awad, Robert H. Spencer et al. · Journal of the American Academy of Dermatology · 2023 · 26 citations · Full text

, , +12

Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center Experience

Mohamed E. Abdelsalam, Ahmed Awad, Ali Baiomy et al. · Cancers · 2023 · 16 citations · Full text

, , +15

1–4 of 4